Researchers identified increases in three miRNAs and decreases in seven miRNAs in patients with type 2 diabetes….
Read More »Yearly Archives: 2014
Charity Miles
Charity Miles iOS/Android Free Sometimes the best way to motivate people to do something for themselves is to make it a way to help others as well. Charity Miles is a free app that empowers your patients to earn money for charities while walking, running or biking everyday. They can choose …
Read More »Letter from the Editor #729
On Friday morning after I got done with a 40 mile bike ride with our local club, we were sitting and talking at our favorite coffee shop when my phone rang. It was a family friend who wanted to talk about her husband’s medications for diabetes. He had been referred …
Read More »Dr. Stanley Schwartz: Thoughts on SGLT-2 Inhibitors
Our publisher, Steve Freed, had a chance to talk with Dr. Stanley Schwartz, asking questions and getting some in-depth and very informative answers on exactly how SGLT-2 Inhibitors work. Steve Freed: Regarding the SGLT2 drugs that are now available, I know that a lot of physicians just refuse to write …
Read More »Obesity 2014 – New Medical Therapies, Part 8
In this Homerun Slides series, we review some issues around the Diabetic Management of the Obese Patient including; Potential Causes of Weight Gain with Treatment of Type 2 Diabetes; Weight Reduction Issues – Non-Insulin; and treatment with SGLT-2 Inhibitors with Incretins (GLP-1’s or DPP-IV’s)…. See more SGLT-2 Resources To download …
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #46: Pharmacotherapy of Type 2 Diabetes, Part 5
Richard S. Beaser, MD This week’s excerpt addresses the following topics: What is the "Incretin Effect"? The seven actions of GLP-1 Efficacy of DPP-IV inhibitors Where do the bile acid sequestrants fit in?
Read More »Eye Chart Pro
Dok LLC Free/iOS Eye Chart Pro is a randomizable visual acuity exam, and can be controlled remotely. It’s useful for triaging, house visits, and for those patients who have memorized the office chart. Features include: Randomizable Snellen Chart; Randomizable Tumbling E Chart; Randomize the whole chart or one line at a time; Smooth …
Read More »Letter from the Editor #728
We have a really interesting item this week that bears reading more than once. Item #4 talks about using glimepiride with patients who are on insulin and how this may be safer and and better than adding more insulin. This article could be turned around to say we should start …
Read More »U-500 Insulin Pen “Coming Soon”
U-500 Insulin Pen "Coming Soon" Because of the many errors reported when using U-500 insulin, Eli Lilly is developing a prefilled pen designed to deliver HUMULIN R U-500 (insulin human), and the company is also working with a development partner on the design of a dedicated U-500 insulin syringe. These …
Read More »Early Obesity Linked to Severe Obesity Later in Life
Using data from the 1999-2010 U.S. NHANES survey, researchers found that men who were obese at age 25 had a 23.1% estimated probability of class III obesity (defined as a BMI greater than 40) after age 35, while men of a normal weight at age 25 only had a 1.1% …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.